Rvl Pharmaceuticals Plc (RVLP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,501 | -11,612 | -51,692 | -33,373 | -18,927 |
| Depreciation Amortization | 14,087 | 93 | 16,748 | 275 | 180 |
| Income taxes - deferred | N/A | 11 | -90 | 38 | N/A |
| Accounts receivable | 1,099 | 1,152 | -898 | N/A | 300 |
| Accounts payable and accrued liabilities | 124 | 224 | -1,370 | 3,226 | 1,659 |
| Other Working Capital | -1,646 | 813 | 4,387 | 8,774 | 4,732 |
| Other Operating Activity | 3,957 | 3,501 | -4,895 | -317 | 776 |
| Operating Cash Flow | $-17,880 | $-5,818 | $-37,810 | $-21,377 | $-11,280 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,184 | -1,225 | -752 | 298 | 67 |
| Net Acquisitions | N/A | N/A | 878 | N/A | N/A |
| Investing Cash Flow | $-2,184 | $-1,225 | $126 | $298 | $67 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 20,810 | -2,409 | N/A |
| Debt Repayment | -5,323 | -4,880 | -2,709 | -6 | -1,806 |
| Common Stock Issued | 92 | 92 | 23,825 | N/A | 119 |
| Common Stock Repurchased | N/A | N/A | N/A | 191 | N/A |
| Other Financing Activity | -89 | -72 | -143 | 42,611 | -131 |
| Financing Cash Flow | $-5,320 | $-4,860 | $41,783 | $40,387 | $-1,818 |
| Beginning Cash Position | 44,543 | 44,543 | 40,444 | 40,444 | 40,444 |
| End Cash Position | 19,159 | 32,640 | 44,543 | 59,752 | 27,413 |
| Net Cash Flow | $-25,384 | $-11,903 | $4,099 | $19,308 | $-13,031 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,880 | -5,818 | -37,810 | -21,377 | -11,280 |
| Capital Expenditure | -2,350 | -1,304 | -752 | -52 | -27 |
| Free Cash Flow | -20,230 | -7,122 | -38,562 | -21,429 | -11,307 |